Hydroquinone and its analogues in dermatology – a potential health risk

@article{Westerhof2005HydroquinoneAI,
  title={Hydroquinone and its analogues in dermatology – a potential health risk},
  author={W. Westerhof and T. Kooyers},
  journal={Journal of Cosmetic Dermatology},
  year={2005},
  volume={4}
}
Hydroquinone has been used for decades as a skin lightening agent. Since January 1, 2001, its use in cosmetics has been banned. This ban is as a result of mid‐term effects such as leukoderma‐en‐confetti/occupational vitiligo and exogenous ochronosis. However, a recent literature search on hydroquinone as a skin lightening agent suggests that possible long‐term effects such as carcinogenesis may be expected as well. 
87 Citations
Hydroquinone and its analogues in dermatology – a risk‐benefit viewpoint
The safety of hydroquinone
Hydroquinone-induced depigmentation: case report and review of the literature.
Hyperpigmentation: Its Historical Treatment and the Development of Hydroquinone
Naturally occurring and synthetic peptides: Efficient tyrosinase inhibitors
Hydroquinone, a benzene metabolite, and leukemia: A case report and review of the literature
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
A new formula for depigmenting human skin.
Mechanism of depigmentation by hydroquinone.
Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition.
Development of a physiologically based pharmacokinetic model for hydroquinone.
...
1
2
3
...